Spain· ES:67075
VIRGAN 1,5 mg/g GEL OFTALMICO
A medicinal product containing ganciclovir, registered in Spain by Laboratoires Thea.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- ganciclovir
- Manufacturer
- Laboratoires Thea
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo6522255EUR 14.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ganciclovir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandVirgan 1,5 mg/g żel do oczuMedezin Sp. z o.o.
- CzechiaVIRGANLaboratoires Thea, Clermont-Ferrand
- FinlandVirgan
- FranceVIRGAN 1,5 mg/g, gel ophtalmiqueTHEA
- NorwayVirganLaboratoires Théa
- BelgiumVirgan 1.5 mg/gLaboratoires Théa
- United StatesZIRGANBausch & Lomb Incorporated
- SwitzerlandVirgan 1.5 mg/g, gel ophtalmiqueTHEA Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Cymevene, Ganciclovir Oresund Pharma
- Belgium · Cymevene, Virgan
- Bulgaria · Ганцикловир Ромфарм
- Czechia · Cymevene, Virgan
- Germany · Cymeven I.V., Ganciclovir Accord
- Denmark · Cymevene, Ganciclovir Oresund Pharma
- Finland · Cymevene, Ganciclovir Bioglan
- France · Cymevan, Ganciclovir Hikma
- United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
- Greece · Gancilen, Virgan
- Croatia · Cymevene
- Hungary · Cymevene, Ganciclovir Rompharm
- Ireland · Cymevene
- Italy · Citovirax, Ganciclovir Accord
- Luxembourg · Cymevene, Virgan
- Netherlands · Cymevene, Ganciclovir Sandoz
- Norway · Cymevene, Ganciclovir Bioglan
- Poland · Cymevene, Ganciclovir Accord
- Portugal · Cymevene, Ganciclovir Accord
- Romania · Ganciclovir Rompharm, Virgan
- Sweden · Cymevene, Ganciclovir Bioglan
- Slovakia · Cymevene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9845753-83e6-401a-b298-c5b54f1e0d68 GET /v1/drugs/c9845753-83e6-401a-b298-c5b54f1e0d68?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1128290400000}",
"nregistro": "67075",
"substance": "ganciclovir"
}See everything about ganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.